The oncogenic role and clinical significance of RNA N6-methyladenosine regulator METTL3 and IGF2BP3 in hepatocellular carcinoma

被引：0
|
作者：
Wang, W. [1 ]
Huang, Y. [1 ]
Wang, S. [1 ]
Yen, C. [1 ]
机构：
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Oncol, Coll Med, Tainan, Taiwan
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-36-006
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [21] MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3
    Li, Di
    Xu, Li
    Liu, Ruyuan
    Yao, Zhaonv
    Zheng, Chuanjun
    Jin, Song
    Guo, Xuefeng
    Zhang, Zhengbao
    Tan, Shengkui
    Zhu, Xiaonian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [22] Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth
    Yang, Ying
    Cai, Qian Qian
    Fu, Li Sheng
    Dong, Yi Wei
    Fan, Fei
    Wu, Xing Zhong
    CHEMISTRY & BIODIVERSITY, 2022, 19 (11)
  • [23] Insights into the role of the N6-methyladenosine reader IGF2BP3 in the progression of oral squamous cell carcinoma and its connection to cell-cycle control
    Song, Dandan
    Dai, Xiaofeng
    Fu, Minna
    Sun, Yang
    Wu, Xingwen
    Zhou, Qianrong
    Bi, Wei
    Sun, Jian
    Yang, Fei
    Yu, Youcheng
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [24] RNA N6-METHYLADENOSINE METHYLTRANSFERASE METTL3 DRIVES NAFLD-HCC THROUGH SUPPRESSING ANTITUMOR IMMUNITY
    Pan, Yasi
    Chen, Huarong
    Wong, Chi Chun
    Zhang, Xiang
    Liu, Weixin
    Ding, Yanqiang
    Huang, Dan
    Song, Qian
    Yu, Jun
    GASTROENTEROLOGY, 2022, 162 (07) : S1123 - S1123
  • [25] The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives
    Pan, Fan
    Lin, Xin-Rong
    Hao, Li-Ping
    Chu, Xiao-Yuan
    Wan, Hai-Jun
    Wang, Rui
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [26] New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
    Li, Yu-jia
    Qiu, Yang-ling
    Li, Meng-ran
    Shen, Min
    Zhang, Feng
    Shao, Jiang-juan
    Xu, Xue-fen
    Zhang, Zi-li
    Zheng, Shi-zhong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (06) : 1130 - 1141
  • [27] Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
    Chen, Pin
    Xu, Jing
    Cui, Zihan
    Wu, Silin
    Xie, Tao
    Zhang, Xiaobiao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Upregulation of METTL3, an N(6) - Adenosine Methyltransferase of PolyA plus RNA in Hepatocellular Carcinoma
    Sachak, Taha
    Barajas, Juan
    Ghoshal, Kalpana
    Knight, Debbie
    Chen, Wei
    Frankel, Wendy L.
    LABORATORY INVESTIGATION, 2018, 98 : 647 - 647
  • [29] N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients
    Wang, Yun
    Li, Tianjun
    Liu, Haiping
    Liang, Yu
    Wang, Guanqun
    Fu, Guangming
    Takatsuki, Mitsuhisa
    Qu, Haijun
    Jing, Fanbo
    Li, Jing
    Jiang, Man
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [30] N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
    Wang, Hong
    Xu, Bei
    Shi, Jun
    GENE, 2020, 722
12345